Why Ramsay Health Care Limited and Sonic Healthcare are better options than the Healthscope IPO

Stick with the leaders and wait for a better entry price point on this IPO.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday, 28 July, private hospital operator and pathology service provider Healthscope will return to the ASX after being taken private in 2010 by private equity groups TPG and The Carlyle Group.

There are two major players here that have done quite well over the past four years in Healthscope's absence and which I believe would be better buys than Healthscope at this point.

Healthcare is regularly a good industry to invest in because of the defensive qualities (lots of sick and injured patients constantly needing care regardless of the current economy). So when Healthscope's return via IPO happens, should investors buy it up or just stick with what they have now in the healthcare space?

— Sonic Healthcare Limited (ASX: SHL) is a pathology and medical imaging diagnostic service provider with an extensive federation of practices in Australia and abroad in the US, the UK and Europe. Several years ago it even tried to buy some of Healthscope's pathology businesses in Queensland, but was blocked by the ACCC.

It has an FY 2015 forward earnings price/earnings ratio of 17, whereas with the initial $2.10 share price that Healthscope is expected to start at it has a forward earnings PE ratio of 21.9. Sonic Healthcare has a market capitalisation of $7.3 billion and Healthscope will start with a $3.6 billion market cap. The dividend yield is 3.6% partially franked. Analyst consensus forecasts have earnings expected to rise about an average 12% annually over the next two years.

Ramsay Health Care Limited (ASX: RHC) is a private hospital and medical centre operator in Australia, France and Indonesia. In Australia, it runs about 69 hospitals, but due to a recent spate of acquisitions, especially in France, its total worldwide network has grown to 151 hospitals and medical centres.

It has an FY 2015 forward earnings PE ratio of 24, so Healthscope will start out between Ramsay and Sonic. Ramsay is a $9.3 billion company, more than double Healthscope and is forecast by analyst consensus to grow earnings about an average 19% annually over the next two years.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »